Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03176394 · ClinicalTrials.gov registry record · NA
Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)
A NA study, sponsored by Next Science TM.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03176394: Clinical Trial NA study, sponsored by Next Science TM.
NCT03176394 is a NA study that was terminated before completion, run by Next Science TM. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03176394, a NA study, was terminated before completion, sponsored by Next Science TM.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a 2-week, single-site, randomized study in adults requiring short-term (≤ 14 days) catheterization. Subjects will be randomized 1:1 to either the biofilm disrupting gel (BLASTX) or SOC (McKesson Jelly) lubricated catheters. Urine and/or catheter DNA analysis will be obtained at catheter insertion, 2, 5, 7 and 14 days after catheterization.
Primary Outcome
Change in microorganisms in the test group compared to the control group.
Interventions
- DEVICE BLASTX Gel
- DEVICE McKesson Jelly
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-05-24 |
| Est. Completion | 2019-10-18 |
| Phase | NA |
Why NCT03176394 stopped before completion
NCT03176394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which BLASTX Gel is the first listed.
NCT03176394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03176394 about?
NCT03176394 is a clinical study titled "Efficacy of BLASTX in Catheter Associated Bacteriuria Versus Standard of Care (SOC)". This is a 2-week, single-site, randomized study in adults requiring short-term (≤ 14 days) catheterization. Subjects will be randomized 1:1 to either the biofilm disrupting gel (BLASTX) or SOC (McKesson Jelly) lubricated catheters. Urine and/or catheter DNA analysis will be obtained at catheter inse...
What is the current status of trial NCT03176394?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2017-05-24. Estimated completion is 2019-10-18.
What interventions are being tested in trial NCT03176394?
The interventions under investigation include: BLASTX Gel (DEVICE), McKesson Jelly (DEVICE).
Who is sponsoring clinical trial NCT03176394?
This trial is sponsored by Next Science TM, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03176394's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI